Advanced Non-Small Cell Lung Cancer With MET Mutations
1 clinical trials · Condition
◉ Watch Advanced Non-Small Cell Lung Cancer With MET Mutations
| Record | Firm | Date |
|---|---|---|
| CNS Dose Escalation/Expansion of Tepotinib in MET-driven NSCLC (NCT04739358) | Criterium, Inc. | 2022-05-25 |
Track Advanced Non-Small Cell Lung Cancer With MET Mutations automatically
Every clearance here is in the API, with alerts when new ones post.